News

We provide the latest news
from the world of economics and finance

08 July
Analysts See 10% Gains Ahead For The Holdings of RDVY

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Rising Dividend Achievers ETF (Symbol: RDVY), we found that the implied analyst target price for the ETF based upon its underlying holdings is $59.63 per unit.

With RDVY trading at a recent price near $54.44 per unit, that means that analysts see 9.53% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of RDVY's underlying holdings with notable upside to their analyst target prices are Elevance Health Inc (Symbol: ELV), Capital One Financial Corp (Symbol: COF), and Equitable Holdings Inc (Symbol: EQH). Although ELV has traded at a recent price of $530.31/share, the average analyst target is 14.81% higher at $608.84/share. Similarly, COF has 10.10% upside from the recent share price of $136.00 if the average analyst target price of $149.74/share is reached, and analysts on average are expecting EQH to reach a target price of $44.30/share, which is 9.60% above the recent price of $40.42. Below is a twelve month price history chart comparing the stock performance of ELV, COF, and EQH:

ELV, COF, and EQH Relative Performance Chart

Combined, ELV, COF, and EQH represent 5.98% of the First Trust Rising Dividend Achievers ETF. Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
First Trust Rising Dividend Achievers ETF RDVY $54.44 $59.63 9.53%
Elevance Health Inc ELV $530.31 $608.84 14.81%
Capital One Financial Corp COF $136.00 $149.74 10.10%
Equitable Holdings Inc EQH $40.42 $44.30 9.60%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

Also see:

High Beta Stocks
PSNL Stock Predictions
Top Ten Hedge Funds Holding BAF

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.